Nex-I, Inc.
- Biotech or pharma, therapeutic R&D
NEX-I(NEXt-generation Immunotherapeutics) is a drug development company with the business goal of discovering factors associated with an immunosuppressive TME. We aim to research, develop, and commercialize First-in-Class anticancer drugs that target these factors.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}